Vitamin D3 in cancer prevention and therapy: The nutritional issue

Hormone Molecular Biology and Clinical Investigation

Volumn 23, Issue 3, 2015, Pages 71-78

  Chirumbolo, Salvatore ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

cancer; Vitamin D

Indexed keywords

CALCITRIOL; COLECALCIFEROL; CYTOKINE; HORMONE; VITAMIN;

CANCER PREVENTION; CANCER THERAPY; CLINICAL TRIAL (TOPIC); HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VITAMIN SUPPLEMENTATION; ADIPOSE TISSUE; ANIMAL; DIET; IMMUNOLOGY; METABOLISM; NEOPLASMS; NUTRITIONAL ASSESSMENT;

ADIPOSE TISSUE; ANIMALS; CHOLECALCIFEROL; CYTOKINES; DIET; HORMONES; HUMANS; NEOPLASMS; NUTRITION ASSESSMENT; VITAMINS;

EID: 84957707494     PISSN: 18681883     EISSN: 18681891     Source Type: Journal    
DOI: 10.1515/hmbci-2015-0011     Document Type: Review

References (88)

1. Revuelta Iniesta R, Rush R, Paciarotti I, Rhatigan EB, Brougham FH, McKenzie JM, Wilson DC. Systematic review and meta-Analysis: prevalence and possible causes of vitamin D deficiency and insufficiency in pediatri c cancer patients. Clin Nutr 2015; doi: 10.1016/j. clnu.2014.12.023.
2. Skaaby T. The relationship of vitamin D status to risk of cardiovascular disease and mortality. Dan Med J 2015;61:pii: B5008.
3. Abbas S, Linseisen J, Rohrmann S, Beulens JW, Buijsse B, Amiano P, Ardanaz E, Balkau B, Boeing H, Clavel-Chapelon F, Fagherazzi G, Franks PW, Gavrila D, Grioni S, Kaaks R, K ey TJ, Khaw KT, Kühn T, Mattiello A, Molina-Montes E, Nilsson PM, Overvad K, Quiró s JR, Rolandsson O, Sacerdote C, Saieva C, Slimani N, Sluijs I, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, Zamora-Ros R, Sharp SJ, Langenberg C, Forouhi NG, Riboli E, Wareham NJ. Dietary vitamin D intake and risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition: the EPIC-InterAct study. Eur J Clin Nutr 2014;68:196-202.
4. Forouhi NG, Ye Z, Rickard AP, Khaw KT, Luben R, Langenberg C, Wareham NJ. Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diab etes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-Analysis of prospective studies. Diabetologia 2012;55:2173-82.
5. Bauer SR,Hankinson SE,Bert one-Johnson ER,Ding EL. Plasma vitamin D levels, menopause, and risk of breast cancer: doseresponse meta-Analysis of prospective studies Medicine ( Baltimore 2013 92, 123-31.
6. Imtiaz S, Siddiqui N. Vitamin-D status at breast cancer diagnosis: correlation with social and environmental factors and dietary intake. J Ayub Med Coll Abbottabad 2014;26:186-90.
7. Neville KA, Walker JL, Cohn RJ, Cowell CT, White CP. The Prevalence of Vitamin D deficiency is higher in adult survivors of childhood cancer. Clin Endocrinol (Oxf) 2015;82:657-62.
8. Podd D. Hypovitaminosis D: a common deficiency with pervasive consequences. J Am Acad Physician Assist 2015;28:20-6.
9. Hoffmann MR, Senior PA, Mager DR. Vitamin D supplementation and health-related quality of life: a systematic review of the literature. J Acad Nutr Diet 2015;115:406-18.
10. Nakamura K, Nashimoto M, Okuda Y, Ota T, Yamamoto M. Fish as a major source of vitamin D in the Japanese diet. Nutrition 2002;18:415-6.
11. Khan N, Yang K, Newmark H, Wong G, Telang N, Rivlin R, Lipkin M. Mammary ductal epithelial cell hyperproliferation and hyperplasia induced by a nutritional stress diet containin g four components of a western-style diet. Carcinogenesis 1994;15:2645-8.
12. Kurihara N, Fan K, Thaler HT, Yang K, Lipkin M. Effect of a Western-style diet fortified with increased calcium a nd vitamin D on mammary gland of C57BL/6 mice. J Med Food 2008;11: 201-6.
13. Newmark HL. Vitamin D adequacy: a possible relationship to breast cancer. Adv Exp Med Biol 1994;364:109-14.
14. Narvaez CJ, Matthews D, LaPorta E, Simmons KM, Beaudin S, Welsh J. The impact of vitamin D in breast cancer: genomics, pathways, metabolism. Front Physiol 2014;5:213.
15. Irving AA, Plum LA, Blaser WJ, Ford MR, Weng C, Clipson L, DeLuca HF, Dove WF. Cholecalciferol or 25-hydroxycholecalciferol neither prevents nor treats adenomas in a rat model of familial colon cancer. J Nutr 2015;145:291-8.
16. Mokady E, Schwartz B, Shany S, Lamprecht SA. A protective role of dietary vitamin D3 in rat colon carcinogenesis. Nutr Cancer 2000;38:65-73.
17. Lou YR, Qiao S, Talonpoika R, Syvälä H, Tuohimaa P. The role of Vitamin D3 metabolism in prostate cancer. J Steroid Biochem Mol Biol 2004;92:317-25.
18. Feldman D, Kr ishnan AV, Swami S, Giovannucci E, Feldman BJ. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer 2014;14:342-57.
19. Chowdhury R, Kunutsor S, Vitezova A, Oliver-Williams C, Chowdhury S, Kiefte-de-Jong JC, Khan H, Baena CP, Prabhakaran D, Hoshen MB, Feldman BS, Pan A, Johnson L, Crowe F, Hu FB, Franco OH. Vitamin D and risk of cause specific death: sy stematic review and meta-Analysis of observational cohort and randomised intervention studies. Br Med J 2014;348:g1903.
20. Holick MF. Sunlight, ultraviolet radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol 2014;810:1-16.
21. Bischoff-Ferrari HA. Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes. Adv Exp Med Biol 2014;810:500-25.
22. Sunshine in a bottle: continuing debate over vitamin D supplements. Are low levels of vitamin D causes of disease-or just indicators of poor lifestyle choices that can foster disease? There's no clear answer yet. Duke Med Health News 20 14;20:4-5.
23. Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE. 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyeliti s. Eur J Immunol 2011;41:822-32.
24. Rolf L, Muris AH, Hupperts R, Damoiseaux J. Vitamin D effects on B cell function in autoimmunity. Ann N Y Acad Sci 2014;1317:84-91.
25. Cantorna MT, Waddell A. The vitamin D receptor turns off chronically activated T cells. Ann N Y Acad Sci 2014;1317:70-5.
26. Chen J,Bruce D,Cantorna MT. Vitamin D receptor expression controls proliferation of naïve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation BMC Immunol 2014 15, 6.
27. Cantorna MT. Why do T cells express the vitamin D receptor? Ann N Y Acad Sci 2011;1217:77-82.
28. Laczmanska I, Laczmanski L, Bebenek M, Karpinski P, Czemarmazowicz H, Ramsey D, Milewicz A, Sasiadek MM. Vitamin D receptor gene polymorphisms in relation to the risk of colorectal cancer in the Polish p opulation. Tumour Biol 2014;35:12397-401.
29. Gandini S, Gnagnarella P, Serrano D, Pasquali E, Raimondi S. Vitamin D receptor polymorphisms and cancer. Adv Exp Med Biol 2014;810:69-105.
30. Khan MI, Bielecka ZF, Najm MZ, Bartnik E, Czarnecki JS, Czarnecka AM, Szczylik C. Vitamin D receptor gene polymorphisms in breast and renal cancer: current state and future approache s (review). Int J Oncol 2014;44:349-63.
31. Huang QQ, Liao YY, Ye XH, Fu JJ, Chen SD. Association between VDR polymorphisms and breast cancer: an updated and comparative meta-Analysis of cru de and adjusted odd ratios. Asian Pac J Cancer Prev 2014;15:847-53.
32. Corgnac S, Perret R, Zhang L, Mach JP, Romero P, Donda A. iNKT/CD1d-Antitumor immunotherapy significantly increases th e efficacy of therapeutic CpG/peptide-based cancer vaccine. J Immunother Cancer 2014;2:39.
33. Yu S, Cantorna MT. The vitamin D receptor is required for iNKT cell development. Proc Natl Acad Sci USA 2008;105:5207-12.
34. Motohashi S, Okamoto Y, Yoshino I, Nakayama T. Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer. Clin Immunol 2011;140:167-76.
35. Yamasaki K, Horiguchi S, Kurosaki M, Kunii N, Nagato K, Hanaoka H, Shimizu N, Ueno N, Yamamoto S, Taniguchi M, Motohashi S, Nakayama T, Okamoto Y. Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy. Clin Immunol 2011;138:255-65.
36. Schneiders FL, de Bruin RC, Santegoets SJ, Bon neville M, Scotet E, Scheper RJ, Verheul HM, de Gruijl TD, van der Vliet HJ. Activated iNKT cells promote V?9V?2-T cell anti-tumor effector functions through the production of TNF-?. Clin Immunol 2012;142:194-200.
37. Bassiri H, Das R, Nichols KE. Invariant NKT cells: killers and conspirators against cancer. Oncoimmunology 2013;2:e27440.
38. Wu L, Gabriel CL, Parekh VV, Van Kaer L. Invariant natural killer T cells: innate-like T cells with potent immunomodulatory activities. Tissue Antigens 2009;73:535-45.
39. Hayes CE, Nashold FE, Spach KM, Pedersen LB. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-grand) 2003;49:277-300.
40. Yuzefpolskiy Y, Baumann FM, Penny LA, Studzinski GP, Kalia V, Sarkar S. V itamin D receptor signals regulate effector and memory CD8 T cell responses to infections in mice. J Nutr 2014;144: 2073-82.
41. Tulk SE, Liao KC, Muruve DA, Li Y, Beck PL, MacDonald JA. Vitamin D(3) metabolites enhance the NLRP3-dependent secretion of IL-1? from human THP-1 monocytic cells. J Cell Biochem 2015;116:711-20.
42. Hsu JW, Yin PN, Wood R, Messing J, Messing E, Lee YF. 1 alpha, 25-dihydroxylvitamin D3 promotes Bacillus Calmette-Guérin immunotherapy of bladder cancer. Oncotarget 2013;4: 2397-406.
43. Yamamoto N, Suyama H, Yamamoto N, Ushijima N. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). Int J Cancer 2008;122:4 61-7.
44. Yamamoto N, Suyama H, Nakazato H, Yamamoto N, Koga Y. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-Activating factor, GcMAF. Cancer Immunol Immuno ther 2008;57:1007-16.
45. Braithwaite MC, Kumar P, Tyagi C, Tomar LK, Choonara YE, Pillay V. Vitamin D therapy and related metabolomics: is the calciferol dose and form the only requirements f or successful clinical therapeutics? Med Hypotheses 2013;81:656-63.
46. Consiglio M, Destefanis M, Morena D, Foglizzo V, Forneris M, Pescarmona G, Silvagno F. The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation. PLoS One 2014;9:e115816.
47. Chirumbolo S. The role of quercetin, flavonols and flavones in modulating inflammatory cell function Inflamm Allergy Drug Targets 2010, 9, 263-85.
48. Shen W, Xue J, Zhao Z, Zhang C. Novel nonsecosteroidal VDR agonists with phenyl-pyrrolyl pentane skeleton. Eur J Med Chem 2013;69:768-78.
49. Zhang HT, Zha ZG, Cao JH, Liang ZJ, Wu H, He MT, Zang X, Yao P, Zhang JQ. Apigenin accelerates lipopolysaccharide induced apoptosis in mesenchymal stem cells through suppressing vitamin D receptor expression. Chin Med J (Engl) 2011;124:3537-45.
50. Chun RF, Liu PT, Modlin RL, Adams JS, Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol 2014;5:151.
51. White JH. Vitamin D metabolism and signaling in the immune system. Rev Endocr Metab Disord 2012;13:21-9.
52. White JH. Regulation of intracrine production of 1,25-dihydroxyvitamin D and its role in innate immune defense against infection. Arch Biochem Biophys 2012;523:58-63.
53. Thyer L, Ward E, Smith R, Fiore MG, Magherini S, Branca JJ, Morucci G, Gulisano M, Ruggiero M, Pacini S. A novel role for a major component of the vitamin D axis: vitamin D binding protein-derived macrophage activating factor induces human breast cancer cell apoptosis through stimulation of macrophages. Nu trients 2013;5:2577-89.
54. Jang W, Kim HJ, Li H, Jo KD, Lee MK, Song SH, Yang HO. 1,25-Dyhydroxyvitamin D3 attenuates rotenone-induced neurotoxicity in SH-SY5Y cells through induction of autophagy. Biochem Biophys Res Commun 2014;451:142-7.
55. Kühne H, Schutkowski A, Weinholz S, Cordes C, Schierhorn A, Schulz K, König B, Stangl GI. Vitamin D receptor regulates i ntestinal proteins involved in cell proliferation, migration and stress response. Lipids Health Dis 2014;13:51.
56. Wong KE, Szeto FL, Zhang W, Ye H, Kong J, Zhang Z, Sun XJ, Li YC. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 200 9;296:E820-8.
57. Kasiappan R, Sun Y, Lungchukiet P, Quarni W, Zhang X, Bai W. Vitamin D suppresses leptin stimulation of cancer growth through microRNA. Cancer Res 2014;74:6194-204 .
58. Andó S, Barone I, Giordano C, Bonofiglio D, Catalano S. The multifaceted mechanism of leptin signaling within tumor microenvironment in driving breast cancer growth and progression. Front Oncol 20 14;4:340.
59. Yan D, Avtanski D, Saxena NK, Sharma D. Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires ?-catenin activation via Akt/GSK3-And MTA1/Wnt1 proteindependent path ways. J Biol Chem 2012;287:8598-612.
60. Zhang Y, Guo Q, Zhang Z, Bai N, Liu Z, Xiong M, Wei Y, Xiang R, Tan X. VDR status arbitrates the prometastatic effects of tumor-Assoc iated macrophages. Mol Cancer Res 2014;12:1181-91.
61. Kong J, Chen Y, Zhu G, Zhao Q, Li YC. 1,25-Dihydroxyvitamin D3 upregulates leptin expression in mouse adipose tissue. J Endocrinol 2013;216:265-71.
62. Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Adipose tissue immunity and cancer. Front Physiol 2013;4:275.
63. Feng H, L iu Q, Zhang N, Zheng L, Sang M, Feng J, Zhang J, Wu X, Shan B. Leptin promotes metastasis by inducing an epithelialmesenchymal transition in A549 lung cancer cells. Oncol Res 2013;21:165-71.
64. Wietrzyk J. [The influence of isoflavonoids on the antitumor activity of vitamin D3]. Postepy Hig Med Dosw (Online). 2007;61:253-60. [In Polish].
65. Wietzke JA, Welsh J. Phytoestrogen r egulation of a Vitamin D3 receptor promoter and 1,25-dihydroxyvitamin D3 actions in human breast cancer cells. J Steroid Biochem Mol Biol 2003;84:149-57.
66. Thangamani S, Kim M, Son Y, Huang X, K im H, Lee JH, Cho J, Ulrich B, Broxmeyer HE, Kim CH. Cutting edge: progesterone directly upregulates vitamin d receptor gene expression for efficient regulation of T cells by calcitriol. J Immunol 2015;194:8 83-6.
67. Pekta M, Kurt AH, U n A, Tiftik RN, Büyükafar K. Effects of 17?-estradiol and progesterone on the production of adipokines in differentiating 3T3-L1 adipocytes: role of Rho-kinase. Cytokine 2015;72:13 0-4.
68. Merhi Z, Doswell A, Krebs K, Cipolla M. Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells. J Clin Endocrinol Metab 2014;99:E1137-45.
69. Gregoraszczuk E?, Rak-Mardya A. Supraphysiological leptin levels shift the profile of steroidogenesis in porcine ovarian follicles toward progesterone and testosterone secretion through increased expressions of CYP11A1 and 17b-H SD: a tissue culture approach. Reproduction 2013 145 311-7.
70. Schwartz B, Yehuda-Shnaidman E. Putative role of adipose tissue in growth and metabolism of colon cancer cells. Front Oncol 2014;4:164.
71. Nieman KM, Romero IL, Van Houten B , Lengyel E. Adipose tissue and adipocytes support tumorigenesis and metastasis. Biochim Biophys Acta 2013;1831:1533-41.
72. Trayhurn P. Hypoxia and adipose tissue function and dysfunction in obesity. Physiol Rev 2013;93:1-21.
73. Bekhite MM, Finkensieper A, Rebhan J, Huse S, Schultze-Mosgau S, Figulla HR, Sauer H, Wartenberg M. Hypoxia, leptin, and vascular endothelial growth factor stim ulate vascular endothelial cell differentiation of human adipose tissue-derived stem cells. Stem Cells Dev 2014;23:333-51.
74. Lapeire L, Hendrix A, Lambein K, Van Bockstal M, Braems G, Van Den Broecke R, Limame R, Mestdagh P, Vandesompele J Vanhove C, Maynard D, Lehué dé C, Muller C, Valet P, Gespach CP, Bracke M, Cocquyt V, Denys H, De Wever O. Cancer-Associated adipose tis sue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling. Cancer Res 2014;74:6806-19.
75. Hu H, Cai Y, Huang J, Zhang J, Deng Y. Visceral adipose tissue and t he risk of colorectal adenomas: a meta-Analysis of observational studies. Eur J Cancer Prev 2014; doi: 10.1097/CEJ.0000000000000113.
76. Ji SQ, Cao J, Zhang QY, Li YY, Yan YQ, Yu FX. Adipose tissued erived stem cells promote pancreatic cancer cell proliferation and invasion. Braz J Med Biol Res 2013;46:758-64.
77. Marcotorchino J, Gouranton E, Romier B, Tourniaire F, Astier J, Malezet C, Amiot MJ, Landrier JF. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res 2012;56:1771-82.
78. Kampmann U, Mosekilde L, Juhl C, Mol ler N, Christensen B, Rejnmark L, Wamberg L, Orskov L. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency-A double-blind, randomized, placebocontrolled trial. Metabolism 2014;63:1115-24.
79. Al-Daghri NM, Al-Attas OS, Alkharfy KM, Khan N, Mohammed AK, Vinodson B, Ansari MG, Alenad A, Al okail MS. Association of VDRgene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency. Gene 2014;542:129-33.
80. Hossein-Nezhad A, Mirzaei K, Keshavarz S A, Ansar H, Saboori S, Tootee A. Evidences of dual role of vitamin D through cellular energy homeostasis and inflammation pathway in risk of cancer in obese subjects. Minerva Med 2013;104:295-307.
81. 1. Alexandre L, Long E, Beales IL. Pathophysiological mechanisms linking obesity and esophageal adenocarcinoma. World J Gastrointest Pathophysiol 2014;5:534-49.
82. Slattery ML, Wolff RK, Herrick J, Caan BJ, Potter JD. Leptin and leptin receptor genotypes and colon cancer: gene-gene and gene-lifestyle interactions. Int J Cancer 2008;122:1611-7.
83. Matarese G, Leiter EH, La Cava A. Leptin in autoimmunity: many questions, some answers. Tissue Antigens 2007;70:87-95.
84. Amarilyo G, Iikuni N, Shi FD, Liu A, Matarese G, La Cava A. Leptin promotes lupus T-cell autoimmunity. Clin Immunol 2013;149:530-3.
85. Cojocaru M, Cojocaru IM, Siloi I, Rogoz S. Role of leptin in autoimmune diseases. Maedica (Buchar) 2013;8:68-74.
86. Cutolo M, Paolino S, Sulli A, Smith V, Pizzorni C, Seriolo B. Vitamin D, steroid hormones, and autoimmunity. Ann N Y Acad Sci 2014;1317:39-46.
87. Ptak A, Kolaczkowska E, Gregoraszczuk EL. Leptin stimulation of cell cycle and inhibition of apoptosis gene and protein expression in OVCAR-3 ovarian cancer cells. Endocrine 2013;43: 394-403 .
88. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011;12:4-18.